ClinicalTrials.gg
RecruitingNCT07890532ContextCareUpdated Oct 22, 2026

AI-Simplified Discharge Summaries to Improve Patient Comprehension (ContextCare)

An interventional study of ContextCare-assisted discharge communication and Standard discharge communication in Patient Discharge and Health Literacy, sponsored by Scarborough Health Network. Recruiting at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-22.

Sponsored by Scarborough Health Network · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Started Aug 2026; still recruiting 2 months later.
Updated Oct 22, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
52
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This randomized pilot study will compare standard hospital discharge communication with discharge summaries simplified using ContextCare, an artificial intelligence-assisted application. The study will enroll 50 adults discharged from Scarborough Health Network. Participants will be assigned to one of two groups in a 1:1 ratio, with allocation stratified by baseline health literacy. The main measure is how well participants explain their diagnosis, treatment, follow-up care, and instructions for seeking further help immediately after receiving discharge information. The study will also assess satisfaction, recall after discharge, and selected post-discharge outcomes.

Read the detailed description

ContextCare produces plain-language discharge instructions from de-identified hospital discharge summaries and adapts the output to the participant's preferred language and information format. Participants in the intervention group receive ContextCare-assisted discharge communication; control participants receive the standard verbal and printed hospital discharge instructions. All participants complete an immediate teach-back assessment across diagnosis, treatment, follow-up care, and return instructions. Baseline health literacy is measured using the Newest Vital Sign (NVS).

The randomized phase follows application development and an internal workflow pilot involving approximately 10 patients. During the workflow pilot, generated summaries are reviewed only by study staff and are not provided to patients or used in clinical care. Workflow pilot data are excluded from the randomized trial analysis; the enrollment target of 50 applies to the randomized phase.

Discharge and teach-back interactions may be video recorded with consent to support independent scoring. The study is open label, with no masking. Statistical analyses compare comprehension between groups and examine the interaction between discharge communication type and baseline health literacy. Qualitative feedback will be analyzed thematically.

02

Conditions studied

  • Patient Discharge
  • Health Literacy

Browse trials for

Keywords

  • Discharge communication
  • Patient comprehension
  • Health literacy
  • Artificial intelligence
  • Teach-back
  • ContextCare
03

In context

Literacy

201 studies on the registry are indexed under Literacy; 69 are open to participants now.

This study's planned enrollment of 52 is below the median of 124 across 170 interventional studies indexed under Literacy.

Browse Literacy studies →

Lead sponsor

This is the only study on the registry with Scarborough Health Network as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older.
  • Medically stable for discharge.
  • Completed discharge summary available.
  • Independently able to participate in consent.
  • Able to understand the consent form in English.

Exclusion criteria

Exclusion Criteria:

  • Age younger than 18 years.
  • Medical instability or acute illness preventing discharge.
  • Has a legally authorized representative or substitute decision maker for conditions including, but not limited to, impaired vision and/or hearing or impaired speech.
  • Discharge summary unavailable at the time of discharge.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
52 participants (estimated)

Study arms

  • Experimental
    ContextCare

    Participants receive AI-simplified discharge instructions generated using ContextCare, tailored to their preferred language and information format, with optional audio and an interactive chat function.

    Behavioral: ContextCare-assisted discharge communication

  • Active comparator
    Standard discharge communication

    Participants receive the standard hospital discharge process, consisting of verbal and printed discharge instructions from hospital staff.

    Behavioral: Standard discharge communication

Interventions

  • BehavioralContextCare-assisted discharge communication

    De-identified discharge summaries are processed by ContextCare using large language models to simplify medical language and organize information under care plan, medications, follow-up appointments, and when to seek help. Output is tailored by language and preferred format and may include audio and interactive follow-up questions.

  • BehavioralStandard discharge communication

    Routine verbal explanation and printed hospital discharge instructions provided by hospital staff.

06

What researchers measure

Primary outcomes

  1. Patient comprehension of discharge instructions: total teach-back score

    Participants explain their diagnosis, treatment, follow-up care, and return instructions in their own words. Each of the four domains is scored from 1 (no comprehension) to 4 (complete comprehension). The total score ranges from 4 to 16, with higher scores indicating better comprehension.

    Time frame: Immediately after discharge instructions are provided

Secondary outcomes

  1. Patient satisfaction with discharge communication

    Participants answer: How clear and helpful was the discharge information you received? Responses range from 1 (not at all clear) to 5 (extremely clear), with higher scores indicating greater perceived clarity and helpfulness.

    Time frame: Immediately after the teach-back assessment at discharge

  2. Recall of discharge information

    Recall of discharge information is assessed by a follow-up telephone call or an in-person check.

    Time frame: 24 to 48 hours after discharge

  3. Hospital readmission

    Hospital readmission within 30 days after discharge.

    Time frame: Within 30 days after discharge

  4. Baseline health literacy: Newest Vital Sign (NVS)

    Health literacy is assessed using a nutrition label and six questions. Scores range from 0 to 6: 0 to 1 indicates a high likelihood of limited literacy, 2 to 3 indicates possible limited literacy, and 4 to 6 indicates adequate literacy. Baseline health literacy is used for stratification and assessment of its association with comprehension.

    Time frame: Before discharge communication and the teach-back assessment

07

Study locations

1 of 1 sites recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — All data will be analyzed and presented in aggregate.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2026 (actual). Primary completion is estimated for Oct 2026, 2 months after the start.

Of 115 non-industry interventional studies with no phase under Literacy, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 20. This study's planned 2 months is below that.

Counting every sponsor, half of 117 studies reached it within 11 months; a quarter within 4 and three quarters within 19.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 15, 2026
First posted
Oct 22, 2026
StartActual
Aug 20, 2026
Primary completionEst.
Oct 30, 2026
CompletionEst.
Oct 30, 2026
Last update
Oct 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 22, 2026
Show all 1 update
  1. Oct 22, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07890532
Lead sponsor
Scarborough Health Network
Responsible party
Joshua S. Landy (Scientist, Scarborough Health Network) — Principal investigator
First posted
Oct 22, 2026
Start date
Aug 20, 2026
Primary completion
Oct 30, 2026 (estimated)
Completion
Oct 30, 2026 (estimated)
Last update
Oct 22, 2026

Study contacts

Joshua Landy
Contact
jlandy@shn.ca
416-300-2010
Joshua Landy
principal investigator · Scarborough Health Network Research Institute (SHNRI)

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion